TimesSquare Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

TimesSquare Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-867,800	Closed	-$99.7M	–	265
2014 Q4	$99.7M	Buy	867,800 +244,900	+39%	+$29.7M	0.55%	58
2014 Q3	$97.3M	Sell	622,900 -740,700	-54%	-$107M	0.55%	54
2014 Q2	$168M	Sell	1,363,600 -307,450	-18%	-$34M	0.91%	22
2014 Q1	$173M	Sell	1,671,050 -224,950	-12%	-$23M	0.91%	26
2013 Q4	$171M	Sell	1,896,000 -260,900	-12%	-$20.8M	0.86%	29
2013 Q3	$144M	Sell	2,156,900 -104,050	-5%	-$7.17M	0.81%	30
2013 Q2	$150M	Buy	+2,260,950	New	+$129M	0.92%	22

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TimesSquare Capital Management's SLXP Position: Q1 2015 in Review

TimesSquare Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 867,800 shares — an estimated $99.7M sold.

TimesSquare Capital Management first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $173M in Q1 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

TimesSquare Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
TimesSquare Capital Management sold 867,800 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $99.7M.
TimesSquare Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
TimesSquare Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $173M in Q1 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on TimesSquare Capital Management's 13F filing for Q1 2015, filed 12 May 2015.